search
Back to results

Vitamin D Deficiency and Postoperative Hypocalcemia

Primary Purpose

Hypocalcemia

Status
Unknown status
Phase
Phase 4
Locations
Brazil
Study Type
Interventional
Intervention
Cholecalciferol
Sponsored by
University of Sao Paulo General Hospital
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional prevention trial for Hypocalcemia focused on measuring hypocalcemia, vitamin D deficiency, cholecalciferol, thyroidectomy

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • patients that will be submitted to total thyroidectomy

Exclusion Criteria:

  • < 18 year-old
  • chronic renal failure (creatinine > 1.5 mg/dL)
  • fasting glucose > 200 mg/dl
  • albumin < 3.5 g/L
  • preoperative use of calcium supplements, bisphosphonates, corticosteroids

Sites / Locations

  • Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo

Arms of the Study

Arm 1

Arm 2

Arm 3

Arm Type

Active Comparator

No Intervention

No Intervention

Arm Label

Vitamin D deficiency treatment

Vitamin D deficiency observation

Vitamin D sufficiency

Arm Description

subjects with 25OHD < 20 ng/mL that will receive 100,000U of cholecalciferol weekly for 4 weeks before surgery

subjects with 25OHD < 20 ng/mL that will not receive cholecalciferol before surgery

controls with 25OHD >= 20 ng/mL that will not receive cholecalciferol before surgery

Outcomes

Primary Outcome Measures

postoperative hypocalcemia

Secondary Outcome Measures

Full Information

First Posted
June 26, 2012
Last Updated
May 10, 2016
Sponsor
University of Sao Paulo General Hospital
search

1. Study Identification

Unique Protocol Identification Number
NCT01632514
Brief Title
Vitamin D Deficiency and Postoperative Hypocalcemia
Official Title
Correction of Vitamin D Deficiency to Prevent Postoperative Hypocalcemia After Thyroidectomy
Study Type
Interventional

2. Study Status

Record Verification Date
May 2016
Overall Recruitment Status
Unknown status
Study Start Date
June 2012 (undefined)
Primary Completion Date
June 2017 (Anticipated)
Study Completion Date
June 2017 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
University of Sao Paulo General Hospital

4. Oversight

Data Monitoring Committee
No

5. Study Description

Brief Summary
Hypocalcemia is a frequent adverse event after thyroidectomy. It is usually related to hypoparathyroidism, but preoperative hypocalcemia, hypomagnesemia or vitamin D deficiency contributes to it. This study aims to determine the frequency of vitamin D deficiency or insufficiency in patients submitted to thyroidectomy, to define the risk attributed to vitamin D deficiency to postoperative hypocalcemia, to identify other factors associated to postoperative calcium disorder, and to evaluate the benefit of preoperative treatment of vitamin D deficiency to prevent postoperative hypocalcemia.
Detailed Description
Subjects to be submitted to total thyroidectomy will be included in the study. The investigators will evaluate serum levels of total calcium, ionic calcium, phosphorus, magnesium, creatinine, albumin, alkaline phosphatase, fasting glucose, thyroid stimulating hormone (TSH), free thyroxin (FT4), intact parathyroid hormone (PTH), 25 hydroxy vitamin D (25OHD), osteocalcin, C-terminal telopeptide (CTX) and procollagen type 1 amino-terminal propeptide (P1NP). Patients will be randomized to 3 groups: (1) 30 subjects with 25OHD < 20 ng/mL that will receive 100,000U of cholecalciferol weekly for 4 weeks before surgery, (2) 30 subjects with 25OHD < 20 ng/mL that will not receive cholecalciferol before surgery and (3) 30 controls with 25OHD >= 20 ng/mL that will not receive cholecalciferol before surgery. Afterwards, the investigators will evaluate immediate postoperative PTH and measure serum levels of total calcium, ionic calcium, magnesium, alkaline phosphatase, osteocalcin, CTX and P1NP in first and second postoperative days for further analysis.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Hypocalcemia
Keywords
hypocalcemia, vitamin D deficiency, cholecalciferol, thyroidectomy

7. Study Design

Primary Purpose
Prevention
Study Phase
Phase 4
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
90 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
Vitamin D deficiency treatment
Arm Type
Active Comparator
Arm Description
subjects with 25OHD < 20 ng/mL that will receive 100,000U of cholecalciferol weekly for 4 weeks before surgery
Arm Title
Vitamin D deficiency observation
Arm Type
No Intervention
Arm Description
subjects with 25OHD < 20 ng/mL that will not receive cholecalciferol before surgery
Arm Title
Vitamin D sufficiency
Arm Type
No Intervention
Arm Description
controls with 25OHD >= 20 ng/mL that will not receive cholecalciferol before surgery
Intervention Type
Drug
Intervention Name(s)
Cholecalciferol
Intervention Description
100,000 U of cholecalciferol weekly for 4 weeks
Primary Outcome Measure Information:
Title
postoperative hypocalcemia
Time Frame
up to 2 days

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: patients that will be submitted to total thyroidectomy Exclusion Criteria: < 18 year-old chronic renal failure (creatinine > 1.5 mg/dL) fasting glucose > 200 mg/dl albumin < 3.5 g/L preoperative use of calcium supplements, bisphosphonates, corticosteroids
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Debora LS Danilovic, M.D., PhD.
Organizational Affiliation
University of Sao Paulo
Official's Role
Principal Investigator
Facility Information:
Facility Name
Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo
City
São Paulo
ZIP/Postal Code
05403-010
Country
Brazil

12. IPD Sharing Statement

Learn more about this trial

Vitamin D Deficiency and Postoperative Hypocalcemia

We'll reach out to this number within 24 hrs